Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects.

Hwang, Inyoung; Park, Sang-In; Lee, SeungHwan; Lee, BackHwan; Yu, Kyung-Sang; Jeon, Ji-Young; Kim, Min-Gul

Hwang, Inyoung; Park, Sang-In; Lee, SeungHwan; Lee, BackHwan; Yu, Kyung-Sang; Jeon, Ji-Young; Kim, Min-Gul.

Afiliação

Hwang I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Republic of Korea.
Park SI; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Republic of Korea.
Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Republic of Korea.
Lee B; Research & Development Division, Alvogen Korea Co., Ltd. Seoul 07326, Republic of Korea.
Yu KS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Republic of Korea.
Jeon JY; Center for Clinical Pharmacology and Biomedical Research Institute, Chonbuk National University Hospital, Jeonju 54907, Republic of Korea.
Kim MG; Center for Clinical Pharmacology and Biomedical Research Institute, Chonbuk National University Hospital, Jeonju 54907, Republic of Korea.

Transl Clin Pharmacol ; 26(1): 16-24, 2018 Mar.

Article em En | MEDLINE | ID: mdl-32055543

Palavras-chave

Bioequivalence; Ezetimibe; Fixed-dose combination; Pharmacokinetics; Rosuvastatin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Transl Clin Pharmacol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google